Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The mouse light/dark box test.

Michel Bourin1, Martine Hascoët

  • 1Faculty of Medicine, EA 3256 Neurobiologie de l'Anxiété et de la Dépression, Faculté de Médecine BP 53508, 44035 Nantes Cedex 1, France. mbourin@sante.univ-nantes.fr

European Journal of Pharmacology
|February 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding Psychotic Depression.

Advances in experimental medicine and biology·2026
Same author

The Diagnosis of Bipolar Disorders: A Major Public Health Issue.

Alpha psychiatry·2025
Same author

Anti-Inflammatory Therapy as a Promising Target in Neuropsychiatric Disorders.

Advances in experimental medicine and biology·2023
Same author

Neurogenesis and Neuroplasticity in Major Depression: Its Therapeutic Implication.

Advances in experimental medicine and biology·2021
Same author

Does endogenous cholecystokinin modulate alcohol intake?

Neuropharmacology·2021
Same author

Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A "Dimmer-Switch" Hypothesis.

Current neuropharmacology·2020
Same journal

Tetrandrine improves obesity-induced adipose metabolic disorders through suppressing macrophage NF-κB activation.

European journal of pharmacology·2026
Same journal

HSP70: From Molecular Chaperone to Integrative Hub in Castration-Resistant Prostate Cancer Therapeutic Resistance.

European journal of pharmacology·2026
Same journal

Network Pharmacology and In Vivo Validation Reveal the Protective Mechanism of 6-Gingerol Against Diabetic Encephalopathy.

European journal of pharmacology·2026
Same journal

Corrigendum to "Piezo1 activation mediates stiffness-induced aortic medial calcification: Pharmacological evidence from agonist and antagonist studies" [Eur. J. Pharmacol. 1011 (2026) 178465].

European journal of pharmacology·2026
Same journal

Early Prediabetes Aggravates Neuroinflammatory and Cognitive Dysfunctional Responses to Chlorpyrifos Exposure: Possible Amelioration by Arachidonic Acid.

European journal of pharmacology·2026
Same journal

Diammonium glycyrrhizinate attenuates neuroinflammation after intracerebral hemorrhage by suppressing VCAM-1 expression via the PI3K-Akt pathway.

European journal of pharmacology·2026
See all related articles

The light/dark test assesses rodent anxiety by measuring aversion to light and exploration. This method effectively detects anxiolytic and anxiogenic compounds in mice.

Area of Science:

  • Neuroscience
  • Behavioral Pharmacology

Background:

  • Rodents exhibit innate aversion to bright areas and explore novel environments.
  • The light/dark test utilizes these behaviors to assess anxiety-like responses.

Purpose of the Study:

  • To evaluate the utility of the light/dark test in predicting anxiolytic-like or anxiogenic-like activity in mice.
  • To highlight the test's ability to detect various classes of anxiolytic compounds.

Main Methods:

  • The test involves a two-compartment apparatus: one dark and safe, the other illuminated and aversive.
  • Measurements include transitions between compartments and time spent in each.
  • The study was developed using male mice, acknowledging strain, weight, and age as potential factors.

Main Results:

Related Experiment Videos

  • Time spent in the illuminated compartment reflects aversion, while transitions indicate activity-exploration.
  • The test can detect classic anxiolytics (benzodiazepines) and newer anxiolytic-like compounds (serotonergic, neuropeptide drugs).

Conclusions:

  • The light/dark test is a valuable tool for predicting anxiolytic and anxiogenic effects in mice.
  • Its simplicity, speed, and lack of need for animal training make it highly practical.